Medtronic plc (MDT)
| Market Cap | 112.33B |
| Revenue (ttm) | 32.58B |
| Net Income (ttm) | 3.93B |
| Shares Out | 1.28B |
| EPS (ttm) | 2.97 |
| PE Ratio | 29.50 |
| Forward PE | 15.76 |
| Dividend | $2.80 (3.20%) |
| Ex-Dividend Date | Sep 27, 2024 |
| Volume | 10,338,105 |
| Open | 87.50 |
| Previous Close | 87.53 |
| Day's Range | 87.04 - 88.72 |
| 52-Week Range | 74.66 - 92.68 |
| Beta | 0.85 |
| Analysts | Hold |
| Price Target | 94.07 (+7.4%) |
| Earnings Date | Nov 19, 2024 |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for MDT stock is "Hold." The 12-month stock price forecast is $94.07, which is an increase of 7.40% from the latest price.
News
Dividend Income: Lanny's October 2024 Summary
Big Oil with BHP Billiton came big with a massive dividend. Canadian Imperial, one of the big 6 Canadian banks, sent a massive $210 dividend my way. There are a few less names now in 2024 than 2023, s...
Beverly Hills surgeon sues Medtronic for patent infringement
A Beverly Hills surgeon is suing Medtronic claiming patent infringement of her hernia repair mesh product. It's the latest in a series of patent challenges against Medtronic.
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Medtronic to announce financial results for its second quarter of fiscal year 2025
GALWAY, Ireland , Nov. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fisca...
CMS grants Transitional Pass-Through Payment for Medtronic Symplicity Spyral™ renal denervation catheter
The Symplicity ™ blood pressure procedure offers patients a new adjunct approach to lowering blood pressure GALWAY, Ireland , Nov. 1, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader i...
My Best Dividend Aristocrats For November 2024
The ProShares S&P 500 Dividend Aristocrats ETF went on a great run during Q3, gaining 11.6% during the quarter. I present 3 strategies that can theoretically beat the dividend aristocrat index in the ...
SPYRAL HTN-ON MED study shows significant, consistent, long-term blood pressure lowering effect at two years
Company commits to advancing clinical data for Symplicity™ with the SPYRAL Gemini clinical trial and expansion of the GSR-DEFINE clinical trial GALWAY, Ireland and WASHINGTON , Oct. 28, 2024 /PRNewswi...
A new paradigm in electrophysiology: Medtronic receives FDA approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter
First-of-its-kind, all-in-one HD-mapping and dual energy (pulsed field and radiofrequency) ablation catheter Highly anticipated by electrophysiologists for its innovation and demonstrated safety and e...
Medtronic: Undervalued Dividend Aristocrat With High Margins
Medtronic remains an attractive investment due to its diversified revenue streams, robust product pipeline and improving margins. MDT's growth is driven by strong performance in Neuroscience, Cardiova...
Buy 4 October Dividend Aristocrats & Watch 10
"Dividend Aristocrats... in the S&P500 Index… have raised their annual payouts every year for at least 25 consecutive years." -- Kiplinger.com/Investing. 67 Aristocrats, screened as of October 7, 2024...
Medtronic voluntarily recalls insulin pumps due to risk of shortened battery life
Company says the smallest knock can impact batteries by damaging internal electronics
Voluntary recall notifying Medtronic insulin pump users of potential risks of shortened pump battery life
Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issue GALWAY, Ireland , Oct. ...
Mexico Spinal Implants Market Size, Share & Trends Analysis 2024-2030, with Focus on Market Leaders ZimVie/Highridge Medical, Medtronic and DePuy Synthes
Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "Mexico Spinal Implants Market Size, Share & Trends Analysis | 2024-2030 | MedSuite | Includes: Cervical Fixation Market, Thoracolumbar Fixation Market, a...
GI Alliance Collaborates with Medtronic to Introduce GI Genius™ AI Technology for Enhanced Colon Polyp Detection
Intelligent endoscopy module to be delivered to more than 400 GI Alliance site locations Intelligent endoscopy module to be delivered to more than 400 GI Alliance site locations
New clinical data demonstrate excellent lesion durability with PulseSelect™ Pulsed Field Ablation System in real-world setting as approvals and adoption expand globally
APHRS: New data confirm robust long-term durability and highly efficient procedure performed without fluoroscopy Successful launch in Japan follows recent reimbursement approval Approvals across APA...
My Best Dividend Aristocrats For October 2024
The ProShares S&P 500 Dividend Aristocrats ETF extends it's good form in the second half of 2024, adding a gain of 3.69% in August. I present 3 strategies that can theoretically beat the dividend aris...
Medtronic expands AiBLE™ spine surgery ecosystem with new technologies and Siemens Healthineers partnership
GALWAY, Ireland and CHICAGO , Sept. 25, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today at the North American Spine Society (NASS) 39th Annual...
Medtronic: This Dividend Aristocrat Is Still A Buy Now
Medtronic is a Dividend Aristocrat with 47 consecutive years of payout growth. The MedTech company exceeded the analyst consensus for revenue and non-GAAP EPS in its fiscal first quarter. Medtronic's ...
Medtronic: An Undervalued Stock With Durable Competitive Advantages
Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) healthcare behemoth. Medtronic has increased its dividend for 47 consecuti...
Final Trades: 3M, Visa, Medtronic and the SPHD
The Investment Committee give you their top stocks to watch for the second half.
Medtronic plc (MDT) 2024 Wells Fargo Healthcare Conference
Medtronic plc (NYSE:MDT) 2024 Wells Fargo Healthcare Conference September 4, 2024 11:35 AM ET Company Participants Geoff Martha - Chairman & CEO Conference Call Participants Larry Biegelsen - Wells F...
Medtronic chairman and CEO Geoff Martha to speak at the Wells Fargo Healthcare Conference
GALWAY, Ireland , Aug. 27, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 2024 Wells Fargo Healthcare Conference on...
PaceMate® Acquires Medtronic Paceart Optima™ System, Bringing Complementary Capabilities to Cardiac Data Management
SARASOTA, Fla.--(BUSINESS WIRE)--PaceMate®, a pioneer in cardiac data management and remote monitoring, announced today the acquisition of the Paceart Optima™ system, an on-premises cardiac workflow s...
Medtronic: Is The Company Back?
Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic remains u...